From: Correlation between immunity from BCG and the morbidity and mortality of COVID-19
COVID-19 cases per 100,000 population | COVID-19 deaths per 100,000 population | |||||
---|---|---|---|---|---|---|
Cases | Total population | BCG coverage < 95% | BCG coverage ≥ 95% | Total population | BCG coverage < 95% | BCG coverage ≥ 95% |
BCG coverage | 0.136 (p = 0.091) | 0–.064 (p = 0.588) | 0.176 (p = 0.111) | 0.061 (p = 0.447) | −0.057 (p = 0.629) | 0.227 (p = 0.038) |
Pulmonary TB – Bacteriologically confirmed | −0.687 (p < 0.0005) | −0.556 (p < 0.0005) | − 0.591 (p < 0.0005) | −0.570 (p < 0.0005) | − 0.574 (p < 0.0005) | −0.333 (p = 0.002) |
Pulmonary TB – Clinically confirmed | −0.699 (p < 0.0005) | −0.674 (p < 0.0005) | − 0.567 (p < 0.0005) | −0.516 (p < 0.0005) | − 0.639 (p < 0.0005) | −0.246 (p = 0.0026) |
Extra-pulmonary TB | −0.652 (p < 0.0005) | −0.626 (p < 0.0005) | − 0.537 (p < 0.0005) | −0.541 (p < 0.0005) | − 0.607 (p < 0.0005) | −0.314 (p = 0.004) |
Overall TB incidence | −0.743 (p < 0.0005) | −0.644 (p < 0.0005) | − 0.663 (p < 0.0005) | −0.611 (p < 0.0005) | − 0.645 (p < 0.0005) | −0.379 (p < 0.0005) |
TB incidence in 15–64-year group | −0.742 (p < 0.0005) | − 0.649 (p < 0.0005) | −0.677 (p < 0.0005) | − 0.621 (p < 0.0005) | −0.646 (p < 0.0005) | − 0.405 (p < 0.0005) |
TB incidence in > 65-year group | − 0.785 (p < 0.0005) | − 0.701 (p < 0.0005) | −0.697 (p < 0.0005) | − 0.647 (p < 0.0005) | −0.704 (p < 0.0005) | − 0.382 (p < 0.0005) |